|
POLR3F expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.339900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.208100E-02 |
| Normal-vs-Stage2 |
4.524800E-01 |
| Normal-vs-Stage3 |
5.117000E-01 |
| Normal-vs-Stage4 |
1.817760E-01 |
| Stage1-vs-Stage2 |
6.981200E-01 |
| Stage1-vs-Stage3 |
6.645000E-01 |
| Stage1-vs-Stage4 |
1.282420E-01 |
| Stage2-vs-Stage3 |
9.934800E-01 |
| Stage2-vs-Stage4 |
2.323800E-01 |
| Stage3-vs-Stage4 |
2.096200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.012180E-02 |
| Normal-vs-AfricanAmerican |
1.684640E-01 |
| Normal-vs-Asian |
1.449010E-01 |
| Caucasian-vs-AfricanAmerican |
4.521400E-01 |
| Caucasian-vs-Asian |
2.197600E-02 |
| AfricanAmerican-vs-Asian |
1.952180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.022000E-02 |
| Normal-vs-Female |
2.361600E-02 |
| Male-vs-Female |
4.108400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.664800E-01 |
| Normal-vs-Extreme_Weight |
2.979000E-01 |
| Normal-vs-Obese |
5.230400E-02 |
| Normal-vs-Extreme_Obese |
4.363800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.572600E-01 |
| Normal_Weight-vs-Obese |
4.495600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.685800E-01 |
| Extreme_Weight-vs-Obese |
3.462400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.856200E-01 |
| Obese-vs-Extreme_Obese |
1.962580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.277970E-01 |
| Normal-vs-Age(41-60Yrs) |
2.903900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.388570E-01 |
| Normal-vs-Age(81-100Yrs) |
2.999200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.971800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.494800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.185600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.441550E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.346000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.425240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.52149999999418E-05 |
| Normal-VS-Type2 PRCC |
2.554800E-01 |
| Normal-VS-KIRP CIMP |
4.646400E-01 |
| Normal-VS-Unclassified PRCC |
6.398100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.83314999999684E-05 |
| Type1 PRCC-VS-KIRP CIMP |
2.871900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.023200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.623200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.064400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.414220E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.374000E-01 |
| Normal-vs-N1 |
2.667400E-01 |
| Normal-vs-N2 |
4.320600E-03 |
| N0-vs-N1 |
1.267790E-01 |
| N0-vs-N2 |
2.883400E-01 |
| N1-vs-N2 |
1.284390E-01 |
|
|
